These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2402308)

  • 1. EPO and renal nutrition--one year later. Evidence lacking in appetite improvement.
    Ellis PW
    Nephrol News Issues; 1990 Jun; 4(6):26, 29, 38. PubMed ID: 2402308
    [No Abstract]   [Full Text] [Related]  

  • 2. [Two new drugs. Recombinant "human" erythropoietin (EPO: Erypo, Recormon)].
    Verwiebe R
    Internist (Berl); 1992 Apr; 33(4):279-81. PubMed ID: 1612854
    [No Abstract]   [Full Text] [Related]  

  • 3. EPO--one year later: a look at rehabilitation. Does EPO impact on rehabilitation of the dialysis patient? A nursing perspective.
    Stevenson K; Binkley LS
    Nephrol News Issues; 1990 Jun; 4(6):30-1. PubMed ID: 2402309
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of recombinant human erythropoietin on soluble interleukin 2 receptor (SIL-2R) levels in haemodialysis patients.
    Altun B; Erdem Y; Haznedaroğlu I; Gürsoy M; Yasavul U; Turgan C; Cağlar S; Kirazli S
    Nephrol Dial Transplant; 1995 Nov; 10(11):2164. PubMed ID: 8643199
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of recombinant human erythropoietin on hospitalization of hemodialysis patients.
    Churchill DN; Muirhead N; Goldstein M; Posen G; Fay W; Beecroft ML; Gorman J; Taylor DW
    Clin Nephrol; 1995 Mar; 43(3):184-8. PubMed ID: 7774076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The efficacy of an erythropoietin-calcitriol combination in patients with chronic kidney failure on programmed hemodialysis].
    Nikolaev AIu; Klepikov PV; Lashutin SV; Kukhtevich AV
    Ter Arkh; 1995; 67(5):27-31. PubMed ID: 7638771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia.
    Fujita Y; Inoue S; Horiguchi S; Kuki A
    Miner Electrolyte Metab; 1995; 21(1-3):50-4. PubMed ID: 7565462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of long-term human recombinant erythropoietin treatment on secretion of pancreatic polypeptide and gastrin in hemodialysed patients with chronic renal failure].
    Nieszporek T; Kokot F; Wiecek A; Marcinkowski W; Rudka R; Trembecki J
    Przegl Lek; 1995; 52(12):590-3. PubMed ID: 8834657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Erythropoietin and transfusions in patients with anemia of chronic renal failure origin : an update view].
    Duclos J; Olea C; Aguirre H; Alvarez MC; Salgado MC
    Rev Med Chil; 1995 Apr; 123(4):451-5. PubMed ID: 8525189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the nutritional status during treatment of anemia using erythropoietin in patients on regular dialysis therapy].
    Eiselt J; Veselá E; Racek J
    Vnitr Lek; 1994 Jul; 40(7):437-9. PubMed ID: 8073661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EPO--one year later. Effects of EPO on nutritional status in CRF.
    Schiro KB
    Nephrol News Issues; 1990 May; 4(5):26, 34. PubMed ID: 2348876
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients.
    Khosroshahi HT; Shoja MM; Tubbs RS; Estakhri R; Ardalan MR
    Transplant Proc; 2007 May; 39(4):1051-3. PubMed ID: 17524889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human erythropoietin administration improves thiamine content in blood and erythrocytes transketolase activity in pre-dialyzed patients.
    Pietrzak I; Baczyk K; Kubiak W
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():29-37. PubMed ID: 8192530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.
    Hussein MM; Mooij JM; Roujouleh H
    Nephrol Dial Transplant; 1994; 9(7):876-7. PubMed ID: 7818713
    [No Abstract]   [Full Text] [Related]  

  • 15. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
    Boran M; Dalva I; Yazicioğlu A; Akbay E; Cetin S
    Int Urol Nephrol; 1993; 25(2):197-203. PubMed ID: 8365853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood rheology and 2,3-diphosphoglycerate levels after erythropoietin treatment.
    Crowley JP; Chazan JA; Metzger JB; Pono L; Valeri CR
    Ann Clin Lab Sci; 1993; 23(1):24-32. PubMed ID: 8430997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated therapies including erythropoietin decrease the incidence of dialysis: lessons from mapping the incidence of end-stage renal disease in Japan.
    Furumatsu Y; Nagasawa Y; Hamano T; Iwatani H; Iio K; Shoji T; Ito T; Tsubakihara Y; Imai E
    Nephrol Dial Transplant; 2008 Mar; 23(3):984-90. PubMed ID: 17956890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Some aspects of current treatment of patients with terminal chronic renal insufficiency].
    Burtsev VI; Grankin VI; Briukhovetskiĭ AG; Klopotskiĭ SA; Miasnikova EB
    Klin Med (Mosk); 1993 Jan; 71(1):33-6. PubMed ID: 8046902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EPO--one year later: a look at rehabilitation. Patient attitude key in impacting the job rate.
    Antonoff A
    Nephrol News Issues; 1990 Jun; 4(6):33-4, 48. PubMed ID: 2402310
    [No Abstract]   [Full Text] [Related]  

  • 20. Vital indication for erythropoietin in a chronic haemodialysis patient. A case report.
    Nielsen OJ; Thaysen JH
    Dan Med Bull; 1989 Dec; 36(6):590-2. PubMed ID: 2612227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.